hsa-miR-499a-5p

ncRNA information

ncRNA name

hsa-miR-499a-5p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PI3K/Akt/PTEN

Cancer information

Cancer name

Pancreatic Cancer

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

5-Fluorouracil

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer

Tissue resource

prostate tissues together with corresponding normal adjacent tissues from prostate patients

human embryonic kidney cell lines 293T

human prostate cell lines Mia-capa2

human prostate cell lines PANC1

human prostate cell lines AsPC-1

human prostate cell liness Capan-2

human pancreas cell lines HPDE6-C7

human 5-5-Fluorouracil-resistant pancreas cell lines ANC1/FU

Experiment

None


Institute

Changhai Hospital

the Chinese Academy of Sciences 

Mei Xuan Biological Science and Technology Ltd

Country

China

China

China

Continent

Asia

Asia

Asia